Drug Shortage Report for BREVICON 0.5/35 TABLETS (21-DAY PACK)

Last updated on 2020-06-30 History
Report ID 119171
Drug Identification Number 02187086
Brand name BREVICON 0.5/35 TABLETS (21-DAY PACK)
Common or Proper name BREVICON 21
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 0.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 21's
ATC code G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-29
Estimated end date 2020-10-09
Actual end date
Shortage status Actual shortage
Updated date 2020-06-30
Company comments Limited inventory available and on preventative allocation.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-06-30 English Compare
v2 2020-06-29 French Compare
v1 2020-06-29 English Compare